Ilika Achieves Manufacturing Milestone for Stereax Micro-Batteries
Why we think this is neutral
This RNS announcement details a manufacturing milestone for Ilika's Stereax micro-battery production, which does not fall into any of the mandatory news categories. While it is a positive development for the company, the information provided does not have a significant impact on the company's financial performance or outlook.
Key Points
- Manufacturing process qualification completed for Ilika's Stereax micro-batteries at Cirtec Medical's US facility
- Production commenced for product testing and initial customer deliveries
- Partnership advances miniaturisation capabilities for implantable medical devices
Summary
Ilika plc (AIM: IKA) has announced a significant manufacturing milestone with its strategic partner Cirtec Medical Corp. The companies have successfully completed the process qualification for the Stereax M300 micro-battery production line at Cirtec Medical's facility in Lowell, Massachusetts. This achievement activates a ten-year manufacturing agreement signed in August 2023, under which Cirtec Medical will produce Ilika's Stereax battery portfolio. Initial deliveries of Stereax M300 batteries to lead customers are targeted to commence in 2025.